DNA Markets Account Types & How to Open

When we set out to review the account offering at DNA Markets, we expected to find a standard menu of retail trading accounts. What we actually found is a broker whose official disclosures are thinner than we would like, and whose public footprint is still being built. DNA Markets is the trading name of Focus Markets Pty Ltd, an Australian-registered company founded in late November 2022, and it operates under a single ASIC licence (no 514425) for market making. That is the extent of the hard regulatory data we hold.

Our review of the account structure relies on the company's own marketing claims and on the limited information available from aggregated industry databases. We have not been able to verify specific spreads, commissions, or minimum deposits from independent sources, and we will not invent figures. Where a detail is not disclosed, we say so plainly. For a trader considering DNA Markets, the absence of transparent account specifications is itself a significant finding.

DNA Markets' own materials describe a range of account types, typically including a standard account, a raw or ECN-style account, and sometimes an Islamic swap-free account. The company claims fast execution, competitive pricing, and tight spreads, and says it offers access to over 800 instruments across forex, commodities, shares, indices, and cryptocurrencies. Those are marketing claims, not verified facts, and we treat them as such.

What we can confirm from the public record is the regulatory wrapper: ASIC licence no 514425, issued to Focus Markets Pty Ltd. ASIC is a well-regarded regulator, and holding a licence is a meaningful baseline. However, ASIC does not approve specific account terms, spreads, or leverage; those are commercial decisions made by the broker. In the absence of published specifications, we cannot tell a trader which account tier would suit them best, or whether the advertised tight spreads are actually available in practice.

We have no verified figures for minimum deposits or maximum leverage at DNA Markets. The company's website and marketing materials may quote numbers, but we have not been able to corroborate them with independent data, and we will not repeat unverified figures. What we can say is that leverage is a double-edged sword: it amplifies both gains and losses, and the appropriate level depends on the trader's experience, capital, and risk tolerance.

For traders in Australia, ASIC imposes leverage limits on retail clients, typically capping forex leverage at 1:30. That is a regulatory safeguard, not a broker choice. For traders outside Australia, the leverage offered may be higher, depending on the entity they are dealing with. We caution that any broker offering very high leverage to retail clients should be scrutinised carefully, especially when the broker's own disclosures are incomplete. In FXCanary's assessment, a trader should never assume that a high-leverage offer is safe simply because the broker holds a licence somewhere.

The cost of trading at DNA Markets is not transparent from the public record. The company claims 'competitive pricing with tight spreads', but we have no independent verification of those spreads, nor of any commission structure. In our experience, brokers that do not publish their full fee schedule often have variable costs that depend on the account type, the instrument, and the liquidity provider. That variability can be a hidden cost for traders.

We recommend that any trader considering DNA Markets asks the broker directly for a complete list of spreads, commissions, and any other fees, and that they compare those figures against the published schedules of established, transparent brokers. If a broker is unwilling to provide a clear breakdown, that is a red flag. In our review, the lack of published cost data is a notable weakness, and we would not advise a trader to open an account without first obtaining a written fee schedule.

We have not been able to confirm which trading platforms DNA Markets offers. The company's marketing materials mention fast execution and a wide range of instruments, but they do not specify whether they support MetaTrader 4, MetaTrader 5, cTrader, or a proprietary platform. That is a significant gap, because the platform is the trader's primary interface with the market, and its reliability, charting tools, and order execution are critical.

In the absence of confirmed platform information, we can only advise traders to ask the broker directly and to test any platform with a demo account before committing real funds. A demo account is the best way to assess execution speed, slippage, and the overall user experience. If DNA Markets does not offer a demo, that would be a further concern. We note that the company's social media presence includes Facebook, Instagram, LinkedIn, and YouTube, which suggests some level of engagement, but that does not substitute for a transparent platform disclosure.

The account opening process at DNA Markets is not documented in the public record. We assume, based on standard industry practice, that it involves submitting personal identification, proof of address, and possibly financial information, but we have not verified the exact steps. ASIC-regulated brokers are required to conduct customer due diligence, so we would expect a KYC process that includes identity verification and possibly a suitability assessment.

Traders should be prepared for a multi-step process that may include document uploads, a waiting period for verification, and a funding step. We recommend that traders read the broker's terms and conditions carefully, especially regarding withdrawal policies and any fees. The FXCanary Scam Risk Score for DNA Markets is 36/100, which we classify as 'Guarded', and our risk flag notes that withdrawal complaints appear in roughly 18% of recent reviews. That is a meaningful signal, and it underscores the importance of understanding the withdrawal process before depositing funds.

We have not been able to confirm whether DNA Markets offers a demo account. For a broker with limited independent reviews and a guarded risk score, a demo account is not just a nice-to-have; it is a vital tool for verifying the broker's claims without risking capital. If DNA Markets does not offer a demo, that would be a significant drawback, as it prevents traders from testing execution, spreads, and platform stability in a risk-free environment.

We advise traders to ask the broker directly about demo availability and to use a demo to test the platform for at least a few weeks, including during volatile market conditions. If the broker is reluctant to provide a demo, or if the demo experience differs markedly from the live experience, that is a warning sign. In our assessment, a broker that is confident in its execution and pricing should welcome a demo trial.

In FXCanary's assessment, DNA Markets presents a mixed picture. On the positive side, it is an ASIC-licensed broker, which provides a regulatory baseline that many offshore brokers lack. The company is registered in Australia, and the licence number (514425) is on the public register. However, the account offering is opaque: we have no verified details on spreads, commissions, minimum deposits, leverage, or platforms, and the company has no employees on record, which is unusual for a broker claiming to offer a full range of services.

The risk score of 36/100, combined with withdrawal complaints in a significant minority of reviews, means that traders should approach with caution. We would not recommend opening a live account until the broker provides full transparency on its account terms and a demonstrable track record of reliable withdrawals. For now, the absence of independent reviews and the lack of detailed disclosures are the story, and a cautious trader would treat DNA Markets as a broker to watch, not a broker to fund.